Potential Use of Multiple Antisense Oligonucleotide Analogs for Cancer Prevention and Therapy
Antisense oligonucleotide (ASO) analogs have been used to counteract the effects of mutated genes and have been developed as therapeutic agents. Several such formulations have been subjected to clinical trials against cancer and have been passed by the FDA for clinical use. However, cancer is a com...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Firenze University Press
2024-03-01
|
Series: | Substantia |
Online Access: | https://riviste.fupress.net/index.php/subs/article/view/2441 |